SCHEMBL24718623

SCHEMBL24718623

NC[C@@H]1CC(=O)N(Cc2cccc(C(F)(F)F)c2)C1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.51
▸ POLB P06746 1/20 0.48
▸ DPP4 P27487 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ DRD2 P14416 1/20 0.46
▸ DRD3 P35462 1/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ LMNA P02545 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ TAAR1 Q96RJ0 1/20 0.44
▸ KCNN4 O15554 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ TEAD1 P28347 1/20 0.44
▸ ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718264 1.00 KMT2A (0.51) KMT2APOLBDPP4KDM4EALDH1A1
SCHEMBL9456619 1.00 KMT2A (0.51) KMT2APOLBDPP4KDM4EALDH1A1
SCHEMBL10912263 0.88 KMT2A (0.53) KMT2APOLBKDM4EALDH1A1GAA
SCHEMBL10709989 0.86 KMT2A (0.41) KMT2APOLBDRD2DRD3KCNH2
SCHEMBL24718391 0.85 KMT2A (0.53) KMT2APOLBKDM4EALDH1A1GAA
SCHEMBL19002479 0.82 KMT2A (0.53) KMT2APOLBKDM4EALDH1A1GAA
SCHEMBL24719106 0.82 KMT2A (0.48) KMT2APOLBDRD2DRD3KCNH2
SCHEMBL24718625 0.82 CA12 (0.47) KMT2APOLBDRD2DRD3KCNH2
SCHEMBL24718399 0.82 CA12 (0.47) KMT2APOLBDRD2DRD3KCNH2
SCHEMBL18997025 0.81 KMT2A (0.52) KMT2APOLBKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 KMT2A 180/4885POLB 1931/4885DPP4 3357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback